Atlas FDA

Abbott RealTime IDH1 Assay

FDA premarket approval P170041/S002 · decided 2019-11-12

Approval details

PMA number
P170041
Supplement
S002
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Abbott RealTime IDH1 Assay
Generic name
Somatic gene mutation detection system
Applicant
Abbott Molecular, Inc.
Date received
2019-10-16
Decision date
2019-11-12
Days to decision
27 days
Decision code
OK30
Product code
OWD
Advisory committee
Medical Genetics
Expedited review
No
Location
Des Plaines, IL
Statement
Update of Quality Procedures for Amplification Reagent Kit and Control Kit.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Alinity m HCV (K252102)Abbott Molecular, Inc.2025-09-25
Alinity m EBV (09N43-095) (K243489)Abbott Molecular, Inc.2025-07-28
Alinity m CMV (K243485)Abbott Molecular, Inc.2025-07-01
Alinity m BKV (K241921)Abbott Molecular, Inc.2025-03-24
Alinity m Resp-4-Plex (K241573)Abbott Molecular, Inc.2025-02-14
Alinity m HSV 1 & 2 / VZV (K233349)Abbott Molecular, Inc.2024-05-03
Alinity m STI Assay (K222379)Abbott Molecular, Inc.2023-03-03
Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m EBV CAL Kit (List No. 09N43-075) (K212778)Abbott Molecular, Inc.2022-07-15